HOOKIPA Pharma Inc.
HOOK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $43,946 | $20,129 | $14,249 | $18,448 |
| % Growth | 118.3% | 41.3% | -22.8% | – |
| Cost of Goods Sold | $2,753 | $3,552 | $3,602 | $4,640 |
| Gross Profit | $41,193 | $16,577 | $10,647 | $13,808 |
| % Margin | 93.7% | 82.4% | 74.7% | 74.8% |
| R&D Expenses | $68,507 | $86,424 | $68,645 | $82,853 |
| G&A Expenses | $20,226 | $18,633 | $18,759 | $17,066 |
| SG&A Expenses | $20,226 | $18,633 | $18,759 | $19,179 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2,113 |
| Other Operating Expenses | -$60,465 | $12,766 | -$3,602 | -$6,550 |
| Operating Expenses | $28,268 | $117,823 | $83,802 | $95,482 |
| Operating Income | -$51,455 | -$97,694 | -$73,155 | -$81,674 |
| % Margin | -117.1% | -485.3% | -513.4% | -442.7% |
| Other Income/Exp. Net | $7,846 | $16,482 | $8,470 | $6,010 |
| Pre-Tax Income | -$43,609 | -$81,212 | -$64,915 | -$75,665 |
| Tax Expense | -$106 | $368 | $0 | $0 |
| Net Income | -$43,503 | -$81,580 | -$64,915 | -$75,665 |
| % Margin | -99% | -405.3% | -455.6% | -410.2% |
| EPS | -3.47 | -8.63 | -9.91 | -23.04 |
| % Growth | 59.8% | 12.9% | 57% | – |
| EPS Diluted | -3.47 | -8.63 | -9.91 | -23.04 |
| Weighted Avg Shares Out | 12,539 | 9,453 | 6,551 | 3,283 |
| Weighted Avg Shares Out Dil | 12,539 | 9,453 | 6,551 | 3,283 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,701 | $5,293 | $1,633 | $27 |
| Interest Expense | $2 | $317 | $687 | $898 |
| Depreciation & Amortization | $2,753 | $3,552 | $3,602 | $4,640 |
| EBITDA | -$40,854 | -$77,343 | -$60,396 | -$70,126 |
| % Margin | -93% | -384.2% | -423.9% | -380.1% |